VETRO, CALOGERO
VETRO, CALOGERO
Università degli Studi di CATANIA
A case of high-risk AML in a patient with advanced systemic mastocytosis
2023-01-01 Fazio, Manlio; Vetro, Calogero; Markovic, Uroš; Duminuco, Andrea; Parisi, Marina; Maugeri, Cinzia; Mauro, Elisa; Parrinello, Nunziatina Laura; Stagno, Fabio; Villari, Loredana; Triolo, Anna Maria; Stella, Stefania; Palumbo, Giuseppe A; Di Raimondo, Francesco; Romano, Alessandra; Zanotti, Roberta
Abnormal F-18 fluorodeoxyglucose uptake of the lung in immunocompromised lymphoma patients in complete remission: Report of two cases and revision of literature
2013-01-01 Conticello, C.; Vetro, C.; Romano, A.; Amato, G.; Schinocca, L.; Cosentino, S.; Ippolito, M.; Giustolisi, R.; Di Raimondo, F.
Advances in understanding regulatory myeloid cells
file da validare2011-01-01 Romano, A.; Vetro, C.; Adriani, M.
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells
2015-01-01 Martelli, Mp; Gionfriddo, I; Mezzasoma, F; Milano, F; Pierangeli, S; Mulas, F; Pacini, R; Tabarrini, A.; Pettirossi, V; Rossi, R; Vetro, C; Brunetti, L; Sportoletti, P; Tiacci, E; Di Raimondo, F; Falini, B
Clinical impact of the immunome in lymphoid malignancies: the role of Myeloid-Derived Suppressor Cells
2015-01-01 Vetro, C; Romano, A; Ancora, Flavia; Coppolino, F; Brundo, M. V.; Raccuia, Sa; Puglisi, F; Tibullo, D; La Cava, P; Giallongo, C; Parrinello, Nl
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells
2021-01-01 Massimino, M.; Vigneri, P.; Stella, S.; Tirro, E.; Pennisi, M. S.; Parrinello, L. N.; Vetro, C.; Manzella, L.; Stagno, F.; Di Raimondo, F.
Endoscopic features of gastro-intestinal lymphomas: From diagnosis to follow-up
2014-01-01 Vetro, C.; Romano, A.; Amico, I.; Conticello, C.; Motta, G.; Figuera, A.; Chiarenza, A.; Di Raimondo, C.; Giulietti, G.; Bonanno, G.; Palumbo, G. A.; Di Raimondo, F.
Hemophagocytic Syndrome in a Patient with ALL: Morphology Still Matters
2021-01-01 Duminuco, Andrea; Palumbo, Giuseppe; Garibaldi, Bruno; Foti, Rosario; Di Raimondo, Francesco; Maugeri, Cinzia; Mauro, Elisa; Fiumara, Paolo; Vetro, Calogero
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database
2021-01-01 Gozzo, L.; Vetro, C.; Brancati, S.; Longo, L.; Vitale, D. C.; Romano, G. L.; Mauro, E.; Fiumara, P. F.; Maugeri, C.; Parisi, M. S.; Dulcamare, I.; Garibaldi, B.; Duminuco, A.; Palumbo, G. A.; Di Raimondo, F.; Drago, F.
Pegylated asparaginase-induced liver injury, a case-based review and data from pharmacovigilance
2022-01-01 Vetro, Calogero; Duminuco, Andrea; Gozzo, Lucia; Maugeri, Cinzia; Parisi, Marina; Brancati, Serena; Longo, Laura; Vitale, Daniela Cristina; Romano, Giovanni Luca; Ciuni, Roberto; Mauro, Elisa; Fiumara, Paolo Fabio; Palumbo, Giuseppe Alberto Maria; Drago, Filippo; Raimondo, Francesco Di
Pegylated liposomal doxorubicin in salvage chemotherapy for multiple myeloma patients
file da validare2013-01-01 Romano, Alessandra; Uccello, Giuseppina; Spina, Paolo; Cunsolo, Rosario; Vetro, Calogero; Di Raimondo, Francesco
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting
2022-01-01 Duminuco, Andrea; Nardo, Antonella; Garibaldi, Bruno; Vetro, Calogero; Longo, Anna; Giallongo, Cesarina; Di Raimondo, Francesco; Palumbo, Giuseppe A
Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy
2018-01-01 Romano, Alessandra; Parrinello, Nunziatina Laura; Vetro, Calogero; Chiarenza, Annalisa; Cerchione, Claudio; Ippolito, Massimo; Palumbo, Giuseppe Alberto; Di Raimondo, Francesco
Proteomic analysis reveals autophagy as pro-survival pathway elicited by long-term exposure with 5-azacitidine in high-risk myelodysplasia
2017-01-01 Romano, Alessandra; Giallongo, Cesarina; Cava, Piera La; Parrinello, Nunziatina L.; Chiechi, Antonella; Vetro, Calogero; Tibullo, Daniele; Raimondo, Francesco Di; Liotta, Lance A.; Espina, Virginia; Palumbo, Giuseppe A.
Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes
2022-01-01 Vetro, C.; Di Giacomo, V.; Mannina, D.; Magrin, S.; Mule, A.; Mitra, M. E.; Siragusa, S.; Duminuco, A.; Garibaldi, B.; Vadala, M. C. E.; Di Raimondo, F.; Palumbo, G. A.
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine
2023-01-01 Palumbo, Giuseppe A; Cambria, Daniela; La Spina, Enrico; Duminuco, Andrea; Laneri, Antonio; Longo, Anna; Vetro, Calogero; Giallongo, Sebastiano; Romano, Alessandra; Di Raimondo, Francesco; Tibullo, Daniele; Giallongo, Cesarina
Saprochete capitata: Emerging Infections from Uncommon Microorganisms in Hematological Diseases
2022-01-01 Duminuco, Andrea; Vetro, Calogero; Maugeri, Cinzia; Mauro, Elisa; Palumbo, Giuseppe A; Parisi, Marina S; Esposito, Benedetta; Giuliano, Giuseppe; Romano, Alessandra; Di Raimondo, Francesco
Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance Data
2023-01-01 Gozzo, Lucia; Nardo, Antonella; Brancati, Serena; Judica, Antongiulio; Duminuco, Andrea; Maugeri, Cinzia; Parisi, Marina; Longo, Laura; Vitale, DANIELA CRISTINA; Ruscica, Rosy; Romano, GIOVANNI LUCA; Mauro, Elisa; Fabio Fiumara, Paolo; Palumbo, Giuseppe Alberto Maria; DI RAIMONDO, Francesco; Vetro, Calogero; Drago, Filippo
Target Therapy for Extramedullary Relapse of FLT3-ITD Acute Myeloid Leukemia: Emerging Data from the Field
2022-01-01 Duminuco, Andrea; Maugeri, Cinzia; Parisi, Marina; Mauro, Elisa; Fiumara, Paolo Fabio; Randazzo, Valentina; Salemi, Domenico; Agueli, Cecilia; Palumbo, Giuseppe Alberto; Santoro, Alessandra; Di Raimondo, Francesco; Vetro, Calogero
The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitors
2023-01-01 Duminuco, Andrea; Vetro, Calogero; Giallongo, Cesarina; Palumbo, Giuseppe Alberto
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A case of high-risk AML in a patient with advanced systemic mastocytosis | 1-gen-2023 | Fazio, Manlio; Vetro, Calogero; Markovic, Uroš; Duminuco, Andrea; Parisi, Marina; Maugeri, Cinzia; Mauro, Elisa; Parrinello, Nunziatina Laura; Stagno, Fabio; Villari, Loredana; Triolo, Anna Maria; Stella, Stefania; Palumbo, Giuseppe A; Di Raimondo, Francesco; Romano, Alessandra; Zanotti, Roberta | |
Abnormal F-18 fluorodeoxyglucose uptake of the lung in immunocompromised lymphoma patients in complete remission: Report of two cases and revision of literature | 1-gen-2013 | Conticello, C.; Vetro, C.; Romano, A.; Amato, G.; Schinocca, L.; Cosentino, S.; Ippolito, M.; Giustolisi, R.; Di Raimondo, F. | |
Advances in understanding regulatory myeloid cells | 1-gen-2011 | Romano, A.; Vetro, C.; Adriani, M. | file da validare |
Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells | 1-gen-2015 | Martelli, Mp; Gionfriddo, I; Mezzasoma, F; Milano, F; Pierangeli, S; Mulas, F; Pacini, R; Tabarrini, A.; Pettirossi, V; Rossi, R; Vetro, C; Brunetti, L; Sportoletti, P; Tiacci, E; Di Raimondo, F; Falini, B | |
Clinical impact of the immunome in lymphoid malignancies: the role of Myeloid-Derived Suppressor Cells | 1-gen-2015 | Vetro, C; Romano, A; Ancora, Flavia; Coppolino, F; Brundo, M. V.; Raccuia, Sa; Puglisi, F; Tibullo, D; La Cava, P; Giallongo, C; Parrinello, Nl | |
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells | 1-gen-2021 | Massimino, M.; Vigneri, P.; Stella, S.; Tirro, E.; Pennisi, M. S.; Parrinello, L. N.; Vetro, C.; Manzella, L.; Stagno, F.; Di Raimondo, F. | |
Endoscopic features of gastro-intestinal lymphomas: From diagnosis to follow-up | 1-gen-2014 | Vetro, C.; Romano, A.; Amico, I.; Conticello, C.; Motta, G.; Figuera, A.; Chiarenza, A.; Di Raimondo, C.; Giulietti, G.; Bonanno, G.; Palumbo, G. A.; Di Raimondo, F. | |
Hemophagocytic Syndrome in a Patient with ALL: Morphology Still Matters | 1-gen-2021 | Duminuco, Andrea; Palumbo, Giuseppe; Garibaldi, Bruno; Foti, Rosario; Di Raimondo, Francesco; Maugeri, Cinzia; Mauro, Elisa; Fiumara, Paolo; Vetro, Calogero | |
Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database | 1-gen-2021 | Gozzo, L.; Vetro, C.; Brancati, S.; Longo, L.; Vitale, D. C.; Romano, G. L.; Mauro, E.; Fiumara, P. F.; Maugeri, C.; Parisi, M. S.; Dulcamare, I.; Garibaldi, B.; Duminuco, A.; Palumbo, G. A.; Di Raimondo, F.; Drago, F. | |
Pegylated asparaginase-induced liver injury, a case-based review and data from pharmacovigilance | 1-gen-2022 | Vetro, Calogero; Duminuco, Andrea; Gozzo, Lucia; Maugeri, Cinzia; Parisi, Marina; Brancati, Serena; Longo, Laura; Vitale, Daniela Cristina; Romano, Giovanni Luca; Ciuni, Roberto; Mauro, Elisa; Fiumara, Paolo Fabio; Palumbo, Giuseppe Alberto Maria; Drago, Filippo; Raimondo, Francesco Di | |
Pegylated liposomal doxorubicin in salvage chemotherapy for multiple myeloma patients | 1-gen-2013 | Romano, Alessandra; Uccello, Giuseppina; Spina, Paolo; Cunsolo, Rosario; Vetro, Calogero; Di Raimondo, Francesco | file da validare |
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting | 1-gen-2022 | Duminuco, Andrea; Nardo, Antonella; Garibaldi, Bruno; Vetro, Calogero; Longo, Anna; Giallongo, Cesarina; Di Raimondo, Francesco; Palumbo, Giuseppe A | |
Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy | 1-gen-2018 | Romano, Alessandra; Parrinello, Nunziatina Laura; Vetro, Calogero; Chiarenza, Annalisa; Cerchione, Claudio; Ippolito, Massimo; Palumbo, Giuseppe Alberto; Di Raimondo, Francesco | |
Proteomic analysis reveals autophagy as pro-survival pathway elicited by long-term exposure with 5-azacitidine in high-risk myelodysplasia | 1-gen-2017 | Romano, Alessandra; Giallongo, Cesarina; Cava, Piera La; Parrinello, Nunziatina L.; Chiechi, Antonella; Vetro, Calogero; Tibullo, Daniele; Raimondo, Francesco Di; Liotta, Lance A.; Espina, Virginia; Palumbo, Giuseppe A. | |
Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes | 1-gen-2022 | Vetro, C.; Di Giacomo, V.; Mannina, D.; Magrin, S.; Mule, A.; Mitra, M. E.; Siragusa, S.; Duminuco, A.; Garibaldi, B.; Vadala, M. C. E.; Di Raimondo, F.; Palumbo, G. A. | |
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine | 1-gen-2023 | Palumbo, Giuseppe A; Cambria, Daniela; La Spina, Enrico; Duminuco, Andrea; Laneri, Antonio; Longo, Anna; Vetro, Calogero; Giallongo, Sebastiano; Romano, Alessandra; Di Raimondo, Francesco; Tibullo, Daniele; Giallongo, Cesarina | |
Saprochete capitata: Emerging Infections from Uncommon Microorganisms in Hematological Diseases | 1-gen-2022 | Duminuco, Andrea; Vetro, Calogero; Maugeri, Cinzia; Mauro, Elisa; Palumbo, Giuseppe A; Parisi, Marina S; Esposito, Benedetta; Giuliano, Giuseppe; Romano, Alessandra; Di Raimondo, Francesco | |
Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance Data | 1-gen-2023 | Gozzo, Lucia; Nardo, Antonella; Brancati, Serena; Judica, Antongiulio; Duminuco, Andrea; Maugeri, Cinzia; Parisi, Marina; Longo, Laura; Vitale, DANIELA CRISTINA; Ruscica, Rosy; Romano, GIOVANNI LUCA; Mauro, Elisa; Fabio Fiumara, Paolo; Palumbo, Giuseppe Alberto Maria; DI RAIMONDO, Francesco; Vetro, Calogero; Drago, Filippo | |
Target Therapy for Extramedullary Relapse of FLT3-ITD Acute Myeloid Leukemia: Emerging Data from the Field | 1-gen-2022 | Duminuco, Andrea; Maugeri, Cinzia; Parisi, Marina; Mauro, Elisa; Fiumara, Paolo Fabio; Randazzo, Valentina; Salemi, Domenico; Agueli, Cecilia; Palumbo, Giuseppe Alberto; Santoro, Alessandra; Di Raimondo, Francesco; Vetro, Calogero | |
The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitors | 1-gen-2023 | Duminuco, Andrea; Vetro, Calogero; Giallongo, Cesarina; Palumbo, Giuseppe Alberto |